Copegus Roche is about £ 3215 for 16 weeks, £ 4,824 for 24 weeks and £ 11,425 for 48 weeks of treatment, while ViraferonPeg ribavirin (Rebetol LS), the health insurance system the return of £ 5540 fixed for a period of 24 weeks or 11,081 £ for 48 weeks of treatment, but was considered both options, the use of cost-effective additional resources.In, was approved by the Institute also short courses in collaboration with one of these drugs – which are associated with less serious side effects – in patients who suffer from rapid response to viral therapy with four weekly (characterized by a very sensitive test) and the appropriate cost of Pegasys plus ribavirin for the system.
Friday, September 24, 2010
Hepatitis C
Copegus Roche is about £ 3215 for 16 weeks, £ 4,824 for 24 weeks and £ 11,425 for 48 weeks of treatment, while ViraferonPeg ribavirin (Rebetol LS), the health insurance system the return of £ 5540 fixed for a period of 24 weeks or 11,081 £ for 48 weeks of treatment, but was considered both options, the use of cost-effective additional resources.In, was approved by the Institute also short courses in collaboration with one of these drugs – which are associated with less serious side effects – in patients who suffer from rapid response to viral therapy with four weekly (characterized by a very sensitive test) and the appropriate cost of Pegasys plus ribavirin for the system.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment